chr7-44104862-T-G
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBS1_Supporting
The NM_001129.5(AEBP1):āc.197T>Gā(p.Val66Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000267 in 1,571,054 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001129.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
AEBP1 | NM_001129.5 | c.197T>G | p.Val66Gly | missense_variant | 1/21 | ENST00000223357.8 | |
AEBP1 | XM_011515162.2 | c.197T>G | p.Val66Gly | missense_variant | 1/20 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
AEBP1 | ENST00000223357.8 | c.197T>G | p.Val66Gly | missense_variant | 1/21 | 1 | NM_001129.5 | P1 | |
AEBP1 | ENST00000455443.5 | c.71T>G | p.Val24Gly | missense_variant | 1/6 | 5 |
Frequencies
GnomAD3 genomes AF: 0.000184 AC: 28AN: 151776Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000412 AC: 7AN: 169766Hom.: 0 AF XY: 0.0000323 AC XY: 3AN XY: 92876
GnomAD4 exome AF: 0.00000986 AC: 14AN: 1419168Hom.: 0 Cov.: 32 AF XY: 0.00000712 AC XY: 5AN XY: 702314
GnomAD4 genome AF: 0.000184 AC: 28AN: 151886Hom.: 0 Cov.: 32 AF XY: 0.000216 AC XY: 16AN XY: 74238
ClinVar
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 26, 2022 | This sequence change replaces valine, which is neutral and non-polar, with glycine, which is neutral and non-polar, at codon 66 of the AEBP1 protein (p.Val66Gly). This variant is present in population databases (rs559299616, gnomAD 0.07%). This variant has not been reported in the literature in individuals affected with AEBP1-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Not Available"; Align-GVGD: "Class C0". The glycine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at